Heidi Leblanc
- Molecular Biology top 5%
- Oncology top 5%
- Immunology top 5%
- Cancer Research top 5%
- Epidemiology top 10%
- Co-authors
- Avi AshkenaziDavid A. LawrencePeter SchowEugene VarfolomeevFrank KischkelSharon FongJohn MorlanDominick Sinicropi
- Topics
- CAR-T cell therapy research (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)Photosynthetic Processes and Mechanisms (3 papers)
- Cited by
- ImmunologyCancer ResearchOncology
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Heidi Leblanc
14 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Biology 1.7k
- Oncology 891
- Immunology 836
- Cancer Research 516
- Epidemiology 307
Countries citing papers authored by Heidi Leblanc
This map shows the geographic impact of Heidi Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Leblanc more than expected).
Fields of papers citing papers by Heidi Leblanc
This network shows the impact of papers produced by Heidi Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Leblanc. The network helps show where Heidi Leblanc may publish in the future.
Co-authorship network of co-authors of Heidi Leblanc
This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Leblanc. A scholar is included among the top collaborators of Heidi Leblanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Leblanc. Heidi Leblanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 39 | |
| 5 | In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primatesbreakdown → | 472 |
| 6 | 149 | |
| 7 | 0 | |
| 8 | 10 | |
| 9 | 202 | |
| 10 | Apo2L/TRAIL and its death and decoy receptorsbreakdown → | 705 |
| 11 | 431 | |
| 12 | 424 | |
| 13 | 37 | |
| 14 | 11 | |
| 15 | 19 |
About Heidi Leblanc
Heidi Leblanc is a scholar working on Immunology, Oncology and Cancer Research, having authored 15 papers that have together received 2.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Photosynthetic Processes and Mechanisms (3 papers). The work is most often cited by research in Immunology (836 citations), Cancer Research (516 citations) and Oncology (891 citations). Heidi Leblanc has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Avi Ashkenazi, David A. Lawrence, Peter Schow, Eugene Varfolomeev, Frank Kischkel, Sharon Fong, John Morlan, Dominick Sinicropi, Ralph Schwall and Klára Tótpál. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.